1. Home
  2. PERI vs DCTH Comparison

PERI vs DCTH Comparison

Compare PERI & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perion Network Ltd.

PERI

Perion Network Ltd.

HOLD

Current Price

$9.80

Market Cap

428.3M

Sector

Technology

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$15.18

Market Cap

398.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PERI
DCTH
Founded
1999
1988
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.3M
398.7M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
PERI
DCTH
Price
$9.80
$15.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$14.50
$22.00
AVG Volume (30 Days)
256.4K
470.5K
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
0.04
Revenue
N/A
N/A
Revenue This Year
$9.98
$24.54
Revenue Next Year
$2.48
$33.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.63
$8.12
52 Week High
$11.27
$15.62

Technical Indicators

Market Signals
Indicator
PERI
DCTH
Relative Strength Index (RSI) 56.67 72.78
Support Level $9.22 $11.19
Resistance Level $9.70 N/A
Average True Range (ATR) 0.23 0.58
MACD 0.01 0.19
Stochastic Oscillator 67.06 96.36

Price Performance

Historical Comparison
PERI
DCTH

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: